KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evolent Health (EVH) EBT (2016 - 2026)

Evolent Health has reported EBT over the past 12 years, most recently at -$430.8 million for Q4 2025.

  • For Q4 2025, EBT fell 1700.81% year-over-year to -$430.8 million; the TTM value through Dec 2025 reached -$534.6 million, down 748.14%, while the annual FY2025 figure was -$534.6 million, 748.14% down from the prior year.
  • EBT for Q4 2025 was -$430.8 million at Evolent Health, down from -$20.0 million in the prior quarter.
  • Over five years, EBT peaked at $2.6 million in Q4 2021 and troughed at -$430.8 million in Q4 2025.
  • A 5-year average of -$44.6 million and a median of -$20.3 million in 2025 define the central range for EBT.
  • Biggest five-year swings in EBT: skyrocketed 126.33% in 2021 and later plummeted 2025.63% in 2023.
  • Year by year, EBT stood at $2.6 million in 2021, then tumbled by 493.35% to -$10.2 million in 2022, then tumbled by 370.0% to -$48.1 million in 2023, then surged by 50.23% to -$23.9 million in 2024, then tumbled by 1700.81% to -$430.8 million in 2025.
  • Business Quant data shows EBT for EVH at -$430.8 million in Q4 2025, -$20.0 million in Q3 2025, and -$20.7 million in Q2 2025.